Results 101 to 110 of about 8,156 (191)

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. [PDF]

open access: yesJ Headache Pain, 2021
Tepper SJ   +11 more
europepmc   +1 more source

Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis. [PDF]

open access: yesNeurol Ther, 2023
Kitamura S   +8 more
europepmc   +1 more source

Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice. [PDF]

open access: yesJ Clin Invest, 2023
Zhu Y   +15 more
europepmc   +1 more source

Educational innovation: the architecture of digital technologies as a catalyst for change in university teacher training. [PDF]

open access: yesSci Rep, 2023
Flores-Chacón E   +5 more
europepmc   +1 more source

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far? [PDF]

open access: yesPharmaceuticals (Basel), 2021
Mavridis T   +5 more
europepmc   +1 more source

Osteochondral Lesions of the Distal Tibial Plafond: A Systematic Review of Lesion Locations and Treatment Outcomes. [PDF]

open access: yesOrthop J Sports Med, 2021
Allahabadi S   +5 more
europepmc   +1 more source

Risk of hypertension in erenumab-treated patients with migraine: Analyses of clinical trial and postmarketing data. [PDF]

open access: yesHeadache, 2021
Dodick DW   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy